296 related articles for article (PubMed ID: 15931575)
21. Dual inhibition of cyclooxygenase-1 and 5-lipoxygenase by aerial part of Bupleurum fruticescens methanol extract.
Prieto JM; Giner RM; Recio MC; Máñez S; Ríos JL
Fitoterapia; 2004 Mar; 75(2):179-86. PubMed ID: 15030922
[TBL] [Abstract][Full Text] [Related]
22. Constituents in Easter lily flowers with medicinal activity.
Francis JA; Rumbeiha W; Nair MG
Life Sci; 2004 Dec; 76(6):671-83. PubMed ID: 15567192
[TBL] [Abstract][Full Text] [Related]
23. Two new isoflavones from Ceiba pentandra and their effect on cyclooxygenase-catalyzed prostaglandin biosynthesis.
Noreen Y; el-Seedi H; Perera P; Bohlin L
J Nat Prod; 1998 Jan; 61(1):8-12. PubMed ID: 9461647
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory activity of tryptanthrin on prostaglandin and leukotriene synthesis.
Danz H; Stoyanova S; Thomet OA; Simon HU; Dannhardt G; Ulbrich H; Hamburger M
Planta Med; 2002 Oct; 68(10):875-80. PubMed ID: 12391548
[TBL] [Abstract][Full Text] [Related]
25. Hypolipidemic and antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed rats.
El-Beshbishy HA; Singab AN; Sinkkonen J; Pihlaja K
Life Sci; 2006 May; 78(23):2724-33. PubMed ID: 16313926
[TBL] [Abstract][Full Text] [Related]
26. Bioactive diels-alder type adducts from the stem bark of Morus macroura.
Dai SJ; Mi ZM; Ma ZB; Li S; Chen RY; Yu DQ
Planta Med; 2004 Aug; 70(8):758-63. PubMed ID: 15368673
[TBL] [Abstract][Full Text] [Related]
27. Variation in antibacterial and anti-inflammatory activity of different growth forms of Malva parviflora and evidence for synergism of the anti-inflammatory compounds.
Shale TL; Stirk WA; van Staden J
J Ethnopharmacol; 2005 Jan; 96(1-2):325-30. PubMed ID: 15588684
[TBL] [Abstract][Full Text] [Related]
28. Bioactivity of alkamides isolated from Echinacea purpurea (L.) Moench.
Clifford LJ; Nair MG; Rana J; Dewitt DL
Phytomedicine; 2002 Apr; 9(3):249-53. PubMed ID: 12046867
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(7):2459-68. PubMed ID: 15755648
[TBL] [Abstract][Full Text] [Related]
30. Flavonoids and stilbenoids with COX-1 and COX-2 inhibitory activity from Dracaena loureiri.
Likhitwitayawuid K; Sawasdee K; Kirtikara K
Planta Med; 2002 Sep; 68(9):841-3. PubMed ID: 12357401
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and effects on the COX-1 and COX-2 activity in human whole blood ex vivo of derivatives containing the [1]benzothienol-[3, 2-d]pyrimidin-4-one heterocyclic system.
Santagati A; Granata G; Marrazzo A; Santagati M
Arch Pharm (Weinheim); 2003 Sep; 336(9):429-35. PubMed ID: 14528491
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of 2-substituted-1-naphthol derivatives on cyclooxygenase I and II.
Kongkathip B; Sangma C; Kirtikara K; Luangkamin S; Hasitapan K; Jongkon N; Hannongbua S; Kongkathip N
Bioorg Med Chem; 2005 Mar; 13(6):2167-75. PubMed ID: 15727869
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of Angelica pubescens f. biserrata on 5-lipoxygenase and cyclooxygenase.
Liu JH; Zschocke S; Reininger E; Bauer R
Planta Med; 1998 Aug; 64(6):525-9. PubMed ID: 9741298
[TBL] [Abstract][Full Text] [Related]
34. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.
Di Nunno L; Vitale P; Scilimati A; Tacconelli S; Patrignani P
J Med Chem; 2004 Sep; 47(20):4881-90. PubMed ID: 15369392
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors.
Khanapure SP; Garvey DS; Young DV; Ezawa M; Earl RA; Gaston RD; Fang X; Murty M; Martino A; Shumway M; Trocha M; Marek P; Tam SW; Janero DR; Letts LG
J Med Chem; 2003 Dec; 46(25):5484-504. PubMed ID: 14640557
[TBL] [Abstract][Full Text] [Related]
37. In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I.
Ottanà R; Carotti S; Maccari R; Landini I; Chiricosta G; Caciagli B; Vigorita MG; Mini E
Bioorg Med Chem Lett; 2005 Sep; 15(17):3930-3. PubMed ID: 15993594
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 enzyme inhibitory triterpenoids from Picrorhiza kurroa seeds.
Zhang Y; Dewitt DL; Murugesan S; Nair MG
Life Sci; 2005 Nov; 77(25):3222-30. PubMed ID: 15979098
[TBL] [Abstract][Full Text] [Related]
39. Flavan-3-ols isolated from some medicinal plants inhibiting COX-1 and COX-2 catalysed prostaglandin biosynthesis.
Noreen Y; Serrano G; Perera P; Bohlin L
Planta Med; 1998 Aug; 64(6):520-4. PubMed ID: 9741297
[TBL] [Abstract][Full Text] [Related]
40. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition.
Geronikaki AA; Lagunin AA; Hadjipavlou-Litina DI; Eleftheriou PT; Filimonov DA; Poroikov VV; Alam I; Saxena AK
J Med Chem; 2008 Mar; 51(6):1601-9. PubMed ID: 18311898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
